Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
Sponsor: Hoffmann-La Roche
Metastatic Colorectal Cancer
United States, Australia, Canada, Denmark, Germany +6 more
- A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin LymphomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Hodgkin Lymphoma
United States, Israel, Italy, Spain, United Kingdom
Sponsor: Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
Sponsor: Hoffmann-La Roche
Diabetic Retinopathy
United States
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis
Australia, France, Germany, Hungary, Italy +6 more
Sponsor: Hoffmann-La Roche
Obesity or Overweight
United States, Argentina, Australia, Belgium, Brazil +15 more
- Study of Zifibancimig in Participants With Neovascular Age-related Macular DegenerationActive Not Recruiting
Sponsor: Hoffmann-La Roche
Macular Degeneration
United States, Puerto Rico
Sponsor: Hoffmann-La Roche
Multiple Myeloma
United States, Canada, Germany, Greece, Israel +6 more
- A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsActive Not Recruiting
Sponsor: Hoffmann-La Roche
ALK Fusion-positive Solid or CNS Tumors
United States, Australia, Brazil, Canada, China +6 more
Sponsor: Hoffmann-La Roche
Obesity or Overweight · Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Canada +15 more
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Austria, Belgium +35 more
Sponsor: Alnylam Pharmaceuticals
Hypertension
United States
- A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionActive Not Recruiting
Sponsor: Hoffmann-La Roche
Primary IgA Nephropathy
United States, Argentina, Australia, Brazil, Canada +16 more
Sponsor: Hoffmann-La Roche
B-Cell Non-Hodgkins Lymphoma
United States, Australia, Canada, France, Germany +2 more
- Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid TumorsRecruiting
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Advanced Solid Tumors
United States, Australia, Canada, China
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Brazil, Mexico, United Kingdom
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
Germany, Switzerland
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
Brazil, China, Croatia, France, Germany +13 more
Sponsor: Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
China
- A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
United States, Argentina, China, Dominican Republic, Finland +18 more
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Belgium, Canada, Germany, Israel +7 more
Sponsor: Hoffmann-La Roche
Urothelial Carcinoma · Non-Small Cell Lung Cancer · Small Cell Lung Cancer · Hepatocellular Carcinoma
Argentina, Austria, Belgium, Brazil, Bulgaria +25 more
Sponsor: Poitiers University Hospital
Permanent Atrial Fibrillation · Preserved Ejection Fraction
Sponsor: Hoffmann-La Roche
Thyroid Eye Disease
United States, Canada, China, France, Israel +5 more
Sponsor: Lene Bergendal Solberg
Hip Fractures · Osteoporosis
Norway